Prothena | PRTA - Trade Creditors


Prothena reported $1.94M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 44.57M 32.32M Jun/2026
Agios Pharmaceuticals USD 16.34M 2.6M Jun/2026
Akebia Therapeutics USD 9.42M 1.04M Jun/2026
ALKERMES USD 142.86M 40.5M Jun/2026
Alnylam Pharmaceuticals USD 108.02M 18.61M Jun/2026
Amgen USD 2.86B 16.65B Jun/2026
Biogen USD 403.9M 45.4M Jun/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Exelixis USD 24.15M 5.47M Mar/2026
Immunic USD 11.01M 873K Mar/2026
Incyte USD 1.39B 1.16B Jun/2026
Ionis Pharmaceuticals USD 47.7M 21.67M Jun/2026
MacroGenics USD 4.29M 500K Mar/2026
Nektar Therapeutics USD 10.03M 744K Mar/2026
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
Prothena USD 1.94M 2.36M Jun/2026
Regeneron Pharmaceuticals USD 1.16B 132.2M Jun/2026
Ultragenyx Pharmaceutical USD 39M 3M Jun/2026
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026